EKF Diagnostics Holdings plc

Equities

EKF

GB0031509804

Advanced Medical Equipment & Technology

Delayed London S.E. 05:06:44 2024-04-25 am EDT 5-day change 1st Jan Change
28.26 GBX +1.85% Intraday chart for EKF Diagnostics Holdings plc +3.15% -10.70%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Onward Opportunities' small-cap strategy yields solid results in 2023 AN
EKF Diagnostics says prospects "promising" but pauses dividends AN
EKF Diagnostics Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
EKF Diagnostics reports trading in line with expectations AN
EKF Diagnostics Holdings plc Provides Earnings Guidance for the Full Year 2023 CI
EKF Diagnostics Holdings plc Announces the Official Opening of its New State-Of-The-Art Life Sciences Manufacturing Site in South Bend, Indiana, United States CI
EARNINGS: FireAngel Safety interim loss widens amid ongoing headwinds AN
Earnings Flash (EKF.L) EKF DIAGNOSTICS HOLDINGS Reports H1 Revenue GBP26.9M MT
EKF Diagnostics Holdings plc Reports Earnings Results for the Half Year Ended June 30, 2023 CI
FTSE 100 Closes Tuesday Up 0.41% as Oil-Price Rises Benefit the Index DJ
EKF Diagnostics hires CFO from Trellus Health, latter names successor AN
FTSE 100 Rises, Led by AB Foods; Smurfit Kappa Slides DJ
Trellus Health's Interim Finance Head Takes Full-time CFO Role at EKF Diagnostics MT
EKF Diagnostics Holdings plc Provides Financial Guidance for the Year Ending 31 December 2023 CI
EKF Diagnostics Holdings plc Appoints Stephen Young as Chief Financial Officer CI
Revolution Bars reports good progress from Peach Pubs AN
FTSE 100 Closes Down 0.2% as Miners Offset Ocado, -2- DJ
FTSE 100 Closes Up 0.5% as Sage Group Shines DJ
SONIA Illiquidity Could Explain Disconnect in BOE Peak Rate Pricing DJ
EKF Diagnostics says CFO Davies resigns to pursue other opportunities AN
EKF Diagnostics CFO Plans Exit; Successor to Assume Role in Q4 MT
Marc Davies to Step Down as Chief Financial Officer of EKF Diagnostics Holdings plc CI
EKF Diagnostics announces enzyme fermenter progress AN
EKF Diagnostics' Enzyme Fermenter Completes Factory Acceptance Testing MT
EKF Diagnostics Holdings plc Announces Its Life Sciences Division's New 14,500L Enzyme Fermentation Capacity Expansion Progress CI
Chart EKF Diagnostics Holdings plc
More charts
EKF Diagnostics Holdings plc is a United Kingdom-based diagnostics company. The Company is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.2775 GBP
Average target price
0.3333 GBP
Spread / Average Target
+20.12%
Consensus
  1. Stock Market
  2. Equities
  3. EKF Stock
  4. News EKF Diagnostics Holdings plc
  5. EKF Diagnostics : To Pay Dividend After Strong COVID-19 Sample Collection Device Demand in FY20